Artemether
Artemether is a medication used for the treatment of malaria. The injectable form is specifically used for severe malaria rather than quinine. In adults, it may not be as effective as artesunate. It is given by injection in a muscle. It is also available by mouth in combination with lumefantrine, known as artemether/lumefantrine.
Clinical data | |
---|---|
Trade names | Many |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intramuscular Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.189.847 |
Chemical and physical data | |
Formula | C16H26O5 |
Molar mass | 298.379 g·mol−1 |
3D model (JSmol) | |
Melting point | 86 to 88 °C (187 to 190 °F) |
SMILES
| |
| |
(what is this?) (verify) |
Artemether causes relatively few side effects. An irregular heartbeat may rarely occur. While there is evidence that use during pregnancy may be harmful in animals, there is no evidence of concern in humans. The World Health Organization (WHO) therefore recommends its use during pregnancy. It is in the artemisinin class of medication.
Artemether has been studied since at least 1981, and has been in medical use since 1987. It is on the World Health Organization's List of Essential Medicines.